Bruckheimer Elchanan, Dagan Tamir, Amir Gabriel, Birk Einat
Section of Pediatric Cardiology, Schneider Children's Medical Center Israel, Petach Tikva, Israel.
Catheter Cardiovasc Interv. 2009 Jul 1;74(1):117-23. doi: 10.1002/ccd.21923.
To report on the early results of treatment of native coarctation of the aorta by implantation and serial dilations of covered stents.
Transcatheter dilation of native coarctation of the aorta carries a risk of aneurysm or rupture. Covered stent implantation requires a large delivery system with the risk of vascular damage.
Covered stents on balloons of diameter sufficient to anchor the stent in the coarctation were implanted using the smallest delivery system possible. Dilation with larger diameter balloons was performed until the pressure gradient was <20 mm Hg and the stent was opposed to the aortic wall.
Twenty-two patients with native coarctation underwent stent implantation. Coarctation diameter increased from 3.6 +/- 1.9 to 12.6 +/- 1.9 mm (P < 0.001). Peak pressure gradient decreased from 29.4 +/- 8.5 to 6.7 +/- 5.7 mm Hg (P < 0.001). Nine patients underwent further dilation on average 5 months later. Residual pressure gradient decreased from 12.3 +/- 5.8 to 2.1 +/- 2.9 mm Hg (P = 0.002). The stent achieved the diameter of the transverse arch in all cases. Complications included a small tear at further dilation treated with a second stent and a femoral pseudoaneurysm. At short-term follow-up of 18.5 months all patients are alive and well with no evidence of recoarctation or aneurysm.
These initial results show that serial dilation of covered Cheatham-Platinum stents is feasible, safe, and an effective percutaneous method for the treatment of native coarctation of the aorta. However, long-term follow up is required.
报告采用覆膜支架植入及序贯扩张治疗主动脉缩窄的早期结果。
经导管扩张主动脉缩窄有动脉瘤或破裂风险。覆膜支架植入需要大型输送系统,存在血管损伤风险。
使用尽可能小的输送系统植入直径足以将支架固定在缩窄部位的球囊上的覆膜支架。用更大直径的球囊进行扩张,直到压力阶差<20 mmHg且支架贴合主动脉壁。
22例主动脉缩窄患者接受了支架植入。缩窄部位直径从3.6±1.9 mm增加至12.6±1.9 mm(P<0.001)。峰值压力阶差从29.4±8.5 mmHg降至6.7±5.7 mmHg(P<0.001)。9例患者平均在5个月后接受了进一步扩张。残余压力阶差从12.3±5.8 mmHg降至2.1±2.9 mmHg(P = 0.002)。所有病例中支架均达到了横弓直径。并发症包括进一步扩张时出现小撕裂,用第二个支架治疗,以及股动脉假性动脉瘤。在18.5个月的短期随访中,所有患者均存活且情况良好,无再缩窄或动脉瘤迹象。
这些初步结果表明,Cheatham-Platinum覆膜支架序贯扩张治疗主动脉缩窄是可行、安全且有效的经皮治疗方法。然而,需要长期随访。